IRMD(IRADIMED CORPORATION) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $41.81M | $53.30M | $65.56M | $73.24M | $83.81M |
| 毛利润 | $32.05M | $41.28M | $50.16M | $56.35M | $64.32M |
| 营业利润 | $9.82M | $15.63M | $20.04M | $21.96M | $26.15M |
| 净利润 | $9.33M | $12.83M | $17.19M | $19.23M | $22.48M |
| 经营现金流 | $11.26M | $10.04M | $13.47M | $25.62M | $24.95M |
| 自由现金流 | $10.78M | $9.22M | $6.02M | $17.62M | $17.18M |
| 摊薄每股收益 | $0.74 | $1.02 | $1.35 | $1.50 | $1.75 |